• Global Fund seeks $14bn to fight AIDS, TB and malaria pharmaceutical-technology
    January 15, 2019
    An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to tackle these serious public health concerns.
  • Global Fund seeks $14bn to fight AIDS, TB and malaria pharmaceutical-technology
    January 15, 2019
    An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to tackle these serious public health concerns.....
  • Researchers develop new treatment for TB pharmaceutical-technology
    January 10, 2019
    A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.
  • Researchers develop new treatment for TB pharmaceutical-technology
    January 10, 2019
    A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.....
  • Manchester team develops non-antibiotic drug against TB biospectrumasia
    October 15, 2018
    The team hopes that the compound developed after 10 years of painstaking research will be tried on humans within three to four years.
  • WHO calls for urgent action to end TB biospectrum
    September 21, 2018
    WHO’s 2018 Global TB Report, released in New York recently, calls for an unprecedented mobilization of national and international commitments.
  • Higher rifampin doses for TB appear more effective with no greater risks europeanpharmaceuticalreview
    July 03, 2018
    Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, were shown to kill more TB bacteria in sputum cultures without increasing the adverse effects of treatment, according to a recent randomised controlled trial.
  • Blood test found to predict onset of TB up to two years in advance europeanpharmaceuticalreview
    April 09, 2018
    A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB…
  • Blood test found to predict onset of TB up to two years in advance europeanpharmaceuticalreview
    April 08, 2018
    A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB…
  • New research into old antibiotic unearths potential improved TB drug europeanpharmaceuticalreview
    December 07, 2017
    A study by the University of Warwick and the Francis Crick Institute has enabled a deeper understanding of the mechanism of action of antibiotic drug, D-cycloserine, which holds promise for future TB treatment.
PharmaSources Customer Service